Evidence map›Paper›PMID 35145687›Full record

ArticleClinical case reports2022

First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature.

Yasamin Kalantari, Afsaneh Sadeghzadeh-Bazargan, Zeinab Aryanian, Parvaneh Hatami, Azadeh Goodarzi

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Ultrasound-guided Treatment of Polycaprolactone Granuloma.Plastic and reconstructive surgery. Global open · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasamin KalantariDepartment of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0001-8443-4591
Afsaneh Sadeghzadeh-BazarganRasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran.
Zeinab AryanianAutoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
Parvaneh HatamiAutoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
Azadeh GoodarziRasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-1249-4429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cases of filler reactions after COVID-19 vaccination have been reported. Here, we present the first case of delayed-type reaction (DTR) to non-hyaluronic acid Polycaprolactone dermal filler after the second dose of Sinopharm COVID-19 vaccine which was improved with administration of topical and intralesional steroids.

Indexed as

adverse effectsaugmentationcase reportcoronaviruscosmeticcosmetic fillerCOVID‐19COVID‐19 vaccinesdelayed‐type reactiondermal fillershyaluronic acidhyaluronic acid fillersnon‐hyaluronic acid fillersreviewside effectsswellingvaccination

Identifiers

PMID35145687
PMCPMC8818279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.